Home › Multiple System Atrophy › Tennessee › Nashville
Multiple System Atrophy clinical trials in Nashville, TN
8 studies for Multiple System Atrophy are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
RecruitingPhase 2
- Teva Investigational Site 15874, Nashville
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Natural History Study of Synucleinopathies
RecruitingObservational study
- Vanderbilt Univeristy, Nashville
CPAP for the Treatment of Supine Hypertension
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
[18F]F-DOPA Imaging in Patients With Autonomic Failure
RecruitingPhase 1Healthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Treatment of Supine Hypertension in Autonomic Failure (CPAP)
Recruiting
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
RecruitingPhase 1
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Multiple System Atrophy trials in other cities
Other studies in Nashville
- Non-Small Cell Lung Cancer96 studies
- Breast Cancer79 studies
- Metastatic Cancer69 studies
- Colorectal Cancer68 studies
- Cancer (all types)64 studies
- Ovarian Cancer48 studies
- Prostate Cancer43 studies
- Pancreatic Cancer40 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Endometrial Cancer37 studies
- Melanoma32 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.